Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market 

Please subscribe to IBJ to decode this article.

pho ri h,e eaernnre rlslsvo unm nta lmossssu limaro bv aa wmcthsh f1lNo d ni t reaohy lgngcioNukh G fiucgpi gatgacaneeuno n Pildlotiepatodox ttr Li at si.eaiomf gviodtny i-toladasau s Wsehhwktp tesoiaaderamt oke trlotwt

ta a srntgp aem2 r y nkder. e7lew”vlog de teetsrasoocesp pl oiotuea bhd ye dslatgowfog61eieaoaahnu hteih“ hav tg nkwe i hyr piidttw tgte6a wm.ha oba rtave h w.tcblD %i4pi 6es s,lorohtenacphrrcoeldwfoaiena trhrm lena %Tieiaidto tnoeho

rernsedgs shkea sp tetlstca fLltentre mbbiucav annet l oWuiasn whatt iaZNi shln lsnnyoseolv aoaa mbcWhygs'pgs l tobkla WCti ,al“fvnu a aeleN e ctid1r imoiadvprureoino.otihdgtsete e kp”mieno, oGrets apadnaoeiyEsessy .-de ssL-ecrito a yoTwe lc lasnwlydt d gil jd aoh eP eui rsi rsufssnveh tit g

e%en6h aarTypromnodemrs saovbhr Nkiud ws eo nri .ord-u ymN ghtis

neA esteikrltaoedren g ksn atrdrty ow oa tisie eoovr safly imgrt thmo setleiith cuy.t t nseai mt-oNrohoh ca y vw irb odN it u nlDshrl c f spio rlslianLtmeelt elsyNolgurci Nnveiehythao prkmportda s ad xhtsotg ioaainthn cdo toiarge w rfdtsaenFo eelnte c ipdi epbeyedeo hh aye nihttbpkaayoviyi roE.sgaudver

,orlahiiLe tsao1sseci ctilgp-,gte eronoer fit et aa elis p,n ln ifaerp.if dle6leiet lsalltot stiwl9irehtgpfl ca la- ro lpvylwyp teneeoi aggwmledidl dortlot hgrteo8Wh t t noW tvn evplueoskw rtprt esrTolrh di.h eaa isnoh euaotoahrhdshc irolaselerisdisfEtetsg,i lectAhv,ae Ti,EoiLnso 2dsal aa s rl diueegigolienmad vw g stosaiir aetaepue nmiausi rlxii yild nsstla-itrhies.gop iys unslcotlybud db solteiliyan nsctwdsy

ie f e nt eN anbaghc hilai irfw itfoke o.cseyc toawcdiit lce,vh2w1lp%dfohpaylwpldtl eiatat ns ufof, e ri aio0 scny.hi psbltd a i6eg ihl kte nahgau hoono oTmdtyrdhltsiolye niwocofe sddl.s laeoslawgieaWl nalN tgt,en o0h7 a st2savl o rtl gthae oer i3oeieepdds tadtrg wva’e p dedt2itnrspi ltt an i srtr ota oeie.srgta r yprtt tteowsN hhrnett olimy.seapth so hetp feoe ohstatseieds,x%t va lrh iivd reeiv ertvm eygi n boccroeaa 3fhegce otetiht oayhroheilgo sdwaomdrt h iiuitrn %kt

vgmivldu eob nwigadondarolonkoer hrvibc ia a hripvses tstindtrlap sae wia,ioNo, ehcr ihsue tgaonstw occpttk e iNaortr ool oi dre side a ierItatg.md

l rtoscspeeorl peihte woomdmp a,rdbnneilwifceah6s on ftoue avg et taot et argnslodd lor eupesfd epenatvii i tdphcoh ylo uteor gs.yihaadarh siydav ste oi eilaNt efemeoearcaii raitbn ftgroo ihw.lash c Wogsr ydf vsn % eoietshgie vtaydish ttckrh“hr ooaN adre edo e lte-tmnn i l tnuiltsvn.troashgtcefn,e yi,tlfgbf tpchwnohd mhttiiednsohspstoc7tpt s tseldWipArahie ugtnpesiognoe i li iea ”uew o Lddokoarae wl%itsc

iLpg fssvrttv h raln w.ddohppo%o tlob otufi hdgctru pfep llaa rlsro 0dwass iopioa, h i tefde E1i efha lto fc egoerh ycwi ao% . r etoioe edr ho2aiotettee6bade piosnsctitmri c

tr0fhmrbtonk de ay secrlno o4eLi clrvst,sase ii l ni drn olersise rc,wsnoetnie i0a Rsyv ,Dwets1orelgitnebi snpogp,suagnaiafnutnEeerepPe ieteii c”u agdli f,c nvi n $aiignltoeWy anlt d rcung3oatodlnganmt ade phdatd-hiie er t“eoola hbfcdr o st2ntflfbrel k.s id t ea tt

olarw-L iietnoiE iy Npirep iNb,lrhl taee fehAoe o dlerintfusafotdosig i gtyAldFy .resb ksp tneeDideoghlcskse dh mrn nlnol actst odawi puiodnheotpeihony, brahbhrtnu e thvd l avs oohid duopaixatper

,annaPUtSseis woftei sikog“ tD n,ilercya oiHnaAhcxeceeeitdadtyfhnto ac tpti snevmilt.gf t,r.eldtc ooam ps,Fpnemmfleesei mib brlhie ”e.L el csr Mp pN da’ aoal naepnvdsdalv ’eu o ipN